Stock Diagnostics - Diagnose before you buy... Monitor what you own
Home FAQs Subscribe Learn More Watch Video Login
Our site has identified 1,419 out of 6,633 companies with severe financial warning signs

Sears (NYSE:S) 49.2% Loss
We warned on Sears at $47.22. Six weeks later stock hits new low price of $24. More...

D&K Healthcare (NASDAQ:DKWD) 70.5% Loss
D and K Healthcare Resources Inc. (DKWD) price dropped to $8.68 four weeks after warning investors to be "extremely cautious" at $29.45. More...

Concord EFS (NYSE:CE) 50.7% Loss
Concord EFS plunges to $16.40 from $33.25 nine weeks after we issued warning. More...

Ticker Company Date of
Diagnosis
Price at
Diagnosis
11-08-02
Price
%
Change
XMM Cross Media Marketing Corp. 05/29/02 $11.85 $0.81 -93.16%
RRI Reliant Resources, Inc. 04/22/02 $16.20 $2.25 -86.11%
ENDO ENDOcare, Inc. 05/24/02 $15.76 $3.04 -80.71%
FLM Fleming Companies, Inc. 05/28/02 $23.09 $6.19 -73.19%
APWR AstroPower, Inc. 05/20/02 $22.63 $6.81 -69.91%

Click here to see how we did it

Earnings are not Reliable
(Click to find out why)

Suprema Specialties, Inc. (CHEZ)

Suprema Specialties, Inc. had Wall Street "buy" recommendations and according to its record earnings this stock looked strong.

EPS (earnings per share) has long been considered by Wall Street to be the leading indicator of a company's financial vitality. However, for Enron this was not the case as it announced "record" EPS in the two quarters prior to its demise. Thus, not one of Wall Street's research analysts, using EPS as their primary indicator, warned investors on Enron.

Click to diagnose
Suprema Specialties

©2002-2005 StockDiagnostics.com  Patents Pending.    
Disclaimer Terms of Service Privacy About Us